The global respiratory drug delivery market is expected to reach $5237 billion by 2021, from $36.1 billion in 2016 with an average annual growth rate of 6% over the forecast period. The growth of this market is primarily driven by increased preference for pulmonary drug delivery pathways, increased development of technology in the form of […]
